Heredity

KENNY ROGERS SHARES WISDOM ON LIFE, LOVE, FAMILY, AND LOSS ON NEW 10-SONG COLLECTION, "LIFE IS LIKE A SONG"

Retrieved on: 
星期三, 四月 12, 2023
Music, Mack, CMA, Forever More, Life, Islands in the Stream, Pain, Collection, Scholar, The New Christy Minstrels, Wonderful Tonight, Ageing, Love, Season, AND, CMT, Wanda Jackson Salutes the Country Music Hall of Fame, Tell Me, Rogers, Heredity, I Will Wait for You, Lionel Richie, Horatio Alger Association of Distinguished Americans, Buddy, AC, LOVE, The People's Choice, Justin, Africa We Go Go, The Temptations, AMA, CMT Music Awards, Edition (book), LOS, Columbia Records, Grasshopper, Family, Universal Music Enterprises, First edition, The Gambler, USA for Africa, Partnership, Malcolm Rogers (curator), SONGS, ACM, Tell Me That You Love Me, R&B, Daytime Friends, Gambling, Love Is a Drug, Nightclub, Film industry, Motown, The New York Times

LOS ANGELES, April 12, 2023 /PRNewswire/ -- Life Is Like A Song, a stunning and emotional new song cycle, featuring previously unreleased gems and coveted rarities performed by the legendary Kenny Rogers, telling the story of the love, life, loss, and faith between Rogers and his family, will be released June 2nd via UMe. The collection, comprising songs from Rogers' archives that were deeply personal to him, will be available on CD and vinyl as well as digitally. The project marks the first new non-Christmas studio album by Rogers in 10 years and the only non-compilation/non-reissued full-length album to be released on vinyl since 1991.

Key Points: 
  • Pre-order Life Is Like A Song here: https://kennyrogers.lnk.to/LifeIsLikeASongPR
    "I think the record is fabulous, and it is going to make Kenny so proud," said Wanda Rogers.
  • "These songs are such a beautiful reminder of his love 'for the feelings a song can make' for a person.
  • "That's Love To Me," penned by Gary Burr and Jim Photoglo, is a beautiful quintessential Kenny Rogers love song.
  • During his lifetime, Rogers was honored with multiple GRAMMYS®, CMA, AMA, ACM, People's Choice, and CMT Music Awards.

Children's Hospital of Philadelphia Receives $10 Million Grant from the Gilbert Family Foundation to Accelerate Neurofibromatosis Research

Retrieved on: 
星期二, 四月 4, 2023
LGG, NF, Brain, Executive, Gene, CHOP, Prevalence, Genetics, Neuro-Oncology (journal), Elective surgery, Pediatrics, Neoplasm, Section, Heredity, HGAP, Hope, Neurofibromatosis, Research, Immunotherapy, VRI, Pain, CAR, Disorder, Neuro-ophthalmology, Genetic disorder, Standard of care, Patient, Investment, Neuro-oncology, HGG, Ophthalmology, Infant, Paratriathlon, NF1, Family, Neurology, BTI, Vision restoration therapy, Disease, Medical imaging, Pharmaceutical industry

PHILADELPHIA, April 4, 2023 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) today announced that it has received more than $10 million in a series of gifts to fund critical neurofibromatosis research from the Gilbert Family Foundation, a private foundation established by Dan and Jennifer Gilbert to accelerate a cure for neurofibromatosis type 1 (NF1). 

Key Points: 
  • The tumors that develop in the brain and body can lead to serious complications, including vision loss and severe pain.
  • The Gilbert Family Foundation was founded in 2015 to help accelerate a cure for NF1.
  • Nick Gilbert, the oldest son of Dan and Jennifer Gilbert, was diagnosed with NF1 as an infant and continues to battle the disease.
  • CHOP has received previous investments for its promising research as part of the Gilbert Family Foundation's Vision Restoration Initiative (VRI).

Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks

Retrieved on: 
星期一, 三月 27, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, Disability studies, Tissue, Heart, Sensory loss, US Foods, Central nervous system, University, CV, Heart failure, Metabolism, Serum, Diabetic neuropathy, Heredity, Pancreas, Ageing, Quality of life, American Academy, Department of Neurology, Xuanwu hospital, Biopharmaceutical, AstraZeneca, Central nervous system disease, Sympathetic nervous system, LICA, Inotersen, Penn Presbyterian Medical Center, Ionis, Muscle weakness, TTR, ATTR, Patient, Orphan, Cardiomyopathy, Diagnosis, Growth, Phase, Polyneuropathy, Death, Safety, Perelman School of Medicine at the University of Pennsylvania, Disease, Medical imaging, Pharmaceutical industry, Science, Neurology

Positive high-level results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed eplontersen met its co-primary endpoints through 66 weeks.

Key Points: 
  • Positive high-level results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed eplontersen met its co-primary endpoints through 66 weeks.
  • The trial also met its third co-primary endpoint demonstrating a statistically significant reduction in serum TTR concentration versus an external placebo group.
  • Eplontersen continued to demonstrate a safety and tolerability profile consistent with that observed at 35 weeks.
  • We are encouraged by the sustained benefit demonstrated by eplontersen and what a self-administered treatment could mean for patients and families affected by ATTRv-PN.

Juvederm® Volux™ Is Now Available from The Spa @ Western Dermatology Consultants

Retrieved on: 
星期四, 三月 23, 2023
Face, Heredity, Consultant, Ageing, Woman, Hyaluronic acid, Albuquerque, New Mexico, Unit cohesion, Spa, Patient, Physiology, Melksham, FDA, Skin, Cosmetics, Injectable filler

As of 2023, women and men seeking a more defined jawline can enjoy the benefits of Juvederm ® Volux™ at Albuquerque ’s The Spa @ Western Dermatology Consultants.

Key Points: 
  • As of 2023, women and men seeking a more defined jawline can enjoy the benefits of Juvederm ® Volux™ at Albuquerque ’s The Spa @ Western Dermatology Consultants.
  • A defined jawline is a classic sign of attractiveness and plays a crucial role in balancing the proportions of the face.
  • The Spa @ Western Dermatology Consultants provides various injectable options for patients who want to reduce wrinkles or enhance facial contours, including the Juvederm® collection of fillers and Restylane® Kysse.
  • Albuquerque’s The Spa @ Western Dermatology Consultants can provide more information about the injectable, as well as other cosmetic treatments available.

Volpara to showcase comprehensive product offerings at NCoBC 2023

Retrieved on: 
星期四, 三月 23, 2023
Insurance, Pancreatic cancer, Professional services, Risk, US Foods, Partnership, PMID, Freedom, Health care, National Consortium for the Study of Terrorism and Responses to Terrorism, Heredity, Cancer, Data collection, Woman, ASX, Redondo Beach, California, Volpara, Breast, Radiology, Patient, Research, FDA, Mammography, Breast cancer, Software, Medical imaging, Nursing, Birth control, Mobile phone

LYNNWOOD, Wash., March 23, 2023 /PRNewswire/ -- Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection of cancer, is attending this year's National Consortium of Breast Centers (NCoBC) conference in Las Vegas to showcase its software advancements that are powering today's progressive breast centers.

Key Points: 
  • Volpara Thumbnail™ goes the extra mile to help patients understand their own breast density with image-enhanced results letters.
  • Volpara Risk Pathways™ provides a smooth workflow for healthcare providers assessing hereditary and lifetime breast cancer risk.
  • Volpara Hive™, the company's customer community, is expanding with a digital hub for networking with other users, sharing best practices, and providing product feedback.
  • To learn more about any of these product advancements, visit Volpara at NCoBC at booth #306 or request a virtual demo .

AMERICAN ACADEMY OF DERMATOLOGY: RESEARCH SUGGESTS CONNECTION BETWEEN HAIR LOSS IN WOMEN AND OTHER DISEASES

Retrieved on: 
星期五, 三月 17, 2023
Dandruff, Hair, Diabetes, Minoxidil, Hair loss, Heredity, Quality of life, Scar, Woman, Acne, Tenderness, American Academy, Research, FAAD, Scalp, Hormone, Howard University College of Medicine, Pain, Dermatology, Traction, MD, Patient, Annual general meeting, Menopause, CCCA, Diagnosis, American Academy of Dermatology, Female, Breast cancer, Disease, Cosmetics, Black

NEW ORLEANS, March 17, 2023 /PRNewswire/ -- Hair loss in women can be emotionally devastating and may negatively impact quality of life, and new research suggests that it can also be associated with having other common medical conditions. A board-certified dermatologist at the American Academy of Dermatology's Annual Meeting in New Orleans will discuss the types of hair loss seen in women with darker skin tones, common types of medical conditions associated with hair loss, and hair loss treatment options. 

Key Points: 
  • A board-certified dermatologist at the American Academy of Dermatology's Annual Meeting in New Orleans will discuss the types of hair loss seen in women with darker skin tones, common types of medical conditions associated with hair loss, and hair loss treatment options.
  • While it's possible to regrow some hair, once the hair follicle scars completely, regrowing hair becomes difficult and hair loss can be permanent.
  • Another common type of hair loss is female pattern hair loss, which affects millions of women of all skin tones.
  • Minoxidil is a common treatment option for female pattern hair loss because it has been shown to reduce hair loss, stimulate hair growth, and strengthen existing strands of hair.

Making the Fight Against Colorectal Cancer a Family Affair

Retrieved on: 
星期四, 三月 2, 2023
Patient, Colorectal cancer, Polyp, Heredity, Survival rate, ACS, CMS, Incidence, Everything I Didn't Say, Death, Colorectal Cancer Alliance, Health, Endoscopy, Risk, Chronic pain, Family, Center for Medicare and Medicaid Innovation, United States Preventive Services Task Force, Communication, Diagnosis, Colonoscopy, City, Lead, Olympus, Disease, American Cancer Society, Centers for Medicare & Medicaid Services, Medicare, Cancer, Extrapyramidal system, CRC, Child, FIT, Mortality, Physician, Mobile phone, Pharmaceutical industry, Birth control, Vaccine, Medicine

CENTER VALLEY, Pa., March 2, 2023 /PRNewswire/ -- Olympus, one of the global leaders in endoscopy, offers a reminder of how important it is to know one's family health history in the fight against colorectal cancer, which may be preventable through a combination of awareness and routine screenings.

Key Points: 
  • The American Cancer Society reports that as many as 1 in 3 people diagnosed with colorectal cancer (CRC) have a family history of the disease.
  • Following his diagnosis, the now 40-year-old learned of cancer histories on both sides of his family, including a grandfather's diagnosis of colon cancer.
  • Olympus understands the importance of colon cancer awareness and as such supports major national colorectal cancer organizations and initiatives as part of National Colorectal Cancer Awareness Month, including:
    Colorectal Cancer Alliance – #theydidntsay national campaign to raise awareness about family health history and Blue Hope Financial Assistance Program.
  • James Casey's music video from his first solo album, featuring artists who have all had colorectal cancer, was sponsored by Olympus.

Global Genetic Toxicology Testing Market Report to 2028: Rising Investments in Pharmaceutical R&D by Companies Drives Growth - ResearchAndMarkets.com

Retrieved on: 
星期四, 一月 26, 2023
Pharmaceutical, Health, Medical Devices, DNA, Toxicity, D, Infection, Agrochemical, Protein, Yale University, Biology, Heredity, Medicine, Drug development, Melanoma, Biomedical Research, Medication, Research, Food, USD, Antibody, Disease, Autoimmune disease, DNA repair, Jackson, R, Food industry, Drug discovery, Cosmetics, Immunosuppression, Pharmaceutical industry, Vaccine

The Global Genetic Toxicology Testing Market size is expected to reach $2.4 billion by 2028, rising at a market growth of 13.2% CAGR during the forecast period.

Key Points: 
  • The Global Genetic Toxicology Testing Market size is expected to reach $2.4 billion by 2028, rising at a market growth of 13.2% CAGR during the forecast period.
  • The genetic toxicology testing research and observes the consequences of numerous physical, biological, and chemical substances on the heredity of live creatures.
  • Agrochemicals, pharmaceutical impurities, chemicals utilized in the cosmetics industry, pharmaceutical medications, and industrial chemicals are all subjected to toxicological studies.
  • The use of in vitro genetic toxicology testing techniques does not permit the assessment of the response induced within a body following secondary infection.

Global Dermatology Devices Market Forecast to 2028 - Featuring Candela, Solta Medical, FotoFinder Systems's, Cynosure and Lumenis Among Others - ResearchAndMarkets.com

Retrieved on: 
星期三, 一月 25, 2023
Health, Medical Supplies, Medical Devices, Light, Laser, Skin, Dermatology, Skin cancer, Plastic, Heredity, Pigment, Food and Drug Administration, Safety, DSM-IV codes, American Society of Plastic Surgeons, Face, Ageing, Food, Epidermis, Dermis, FDA, Growth, ASPS, Society, Cryosurgery, COVID-19, Psoriasis, Cosmetics

The "Dermatology Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, End User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Dermatology Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, End User" report has been added to ResearchAndMarkets.com's offering.
  • The global dermatology device market is expected to grow from US$ 5,408.57 million in 2021 to US$ 11,235.42 million by 2028.
  • The growth of the global dermatology device market is attributed due to a rise in the number of aesthetic procedures performed every year.
  • Dermatology is a specialty that employs a wide range of medical devices, from cosmetic applications to medical dermatology.

Breast Cancer Drugs Global Market Report 2023

Retrieved on: 
星期四, 二月 16, 2023
Cataract, Organization, Brain, Spinal cord, Mitosis, Woman, Drug combination, Hospital, Genzyme, Heredity, Ductal carcinoma, HER2, World Health Organization, Breast cancer, Osteoporosis, Novartis, Thrombus, Patient, Geography, EMA, Food, Merative, Pamidronic acid, Cell division, Celgene, European Medicines Agency, Infertility, Triple-negative breast cancer, Eli Lilly, Research report, Enzyme inhibitor, Pregnancy, Partnership, Food and Drug Administration, Prevalence, AstraZeneca, COVID-19, Overalls, Headache, Cancer, Pharmaceutical industry, Birth control, Dietary supplement, European, Anastrozole

Microtubules, that pull the chromosomes apart as a cell divides, are disrupted by these medications.The different types include metastatic breast cancer, triple-negative breast cancer, and others (ductal carcinoma in situ, invasive ductal carcinoma, inflammatory breast cancer, breast cancer during pregnancy, and others).

Key Points: 
  • Microtubules, that pull the chromosomes apart as a cell divides, are disrupted by these medications.The different types include metastatic breast cancer, triple-negative breast cancer, and others (ductal carcinoma in situ, invasive ductal carcinoma, inflammatory breast cancer, breast cancer during pregnancy, and others).
  • As the number of people diagnosed with breast cancer rises, the demand for breast cancer drugs increases, thereby driving the market growth.
  • Adverse side effects caused by the use of breast cancer drugs are acting as a restraint on the breast cancer drugs market.Breast cancer drugs can result in long-term or short-term side effects including headaches, dental issues, osteoporosis, heart problems, cataracts, blood clots, infertility, and others.
  • The breast cancer drugs market research report is one of a series of new reports that provides breast cancer drugs market statistics, including breast cancer drugs industry global market size, regional shares, competitors with a breast cancer drugs market share, detailed breast cancer drugs market segments, market trends and opportunities, and any further data you may need to thrive in the breast cancer drugs industry.